We are live on
!
Find out more
FCMI
Foresite Capital Management I Portfolio holdings
AUM
$21.4M
1-Year Est. Return
80.48%
This Fund
S&P 500
This Quarter
Est. Return
-40.52%
1 Year Est. Return
-80.48%
3 Year Est. Return
-40.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$33.9M
AUM Growth
-$23.3M
(-41%)
Cap. Flow
-$165K
Cap. Flow
% of AUM
-0.49%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EPZM
Epizyme, Inc
EPZM
|
+$165K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
A
CVGI
AEPI
AGDR
N
WL
NVPX
SVGI
Foresite Capital Management I's Q2 2022 Portfolio in Review
As of Q2 2022, Foresite Capital Management I held 2 positions worth $33.9M, down 41% from $57.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Foresite Capital Management I's Q2 2022 filing shows 1 closed position. The largest sale was Epizyme, Inc, an estimated $165K.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Foresite Capital Management I fully exited Epizyme, Inc in Q2 2022, selling an estimated $165K.
- Foresite Capital Management I's ten largest holdings make up 100% of its $33.9M portfolio in Q2 2022.
- Foresite Capital Management I opened 0 new positions and closed 1 in Q2 2022.
- Foresite Capital Management I's portfolio value fell 41% quarter-over-quarter to $33.9M.
Based on Foresite Capital Management I's 13F filing for Q2 2022, filed 12 Aug 2022.